tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Charles Duncan - 312 which are a Buy (91.5%), 29 which are a Hold (8.5%)
Analyst Charles Duncan works at CANTOR FITZGERALD and is covering Healthcare, Industrials sectors with 621 price targets and ratings displayed on 50 stocks. Previously, Charles Duncan worked at PIPER SANDLER.
Charles Duncan's average stock forecast success ratio is 50.31% with an average time for price targets to be met of 192.04 days.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 07-Nov-2023.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 3/3/2020. The price target of $12 was fulfilled within 3 days with a profit of $4.55 (61.07%) receiving and performance score of 203.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
35
$12.15 (53.17%)
20
1 months ago
4/7 (57.14%)
$1.01 (4.50%)
32
Hold
31
$8.15 (35.67%)
30
1 months 3 days ago
15/17 (88.24%)
$4.69 (20.15%)
193
Buy
33
$10.15 (44.42%)
33
1 months 3 days ago
10/15 (66.67%)
$9.01 (41.66%)
235
Buy
42
$19.15 (83.81%)
39
1 months 3 days ago
9/14 (64.29%)
$8.64 (37.89%)
235
Hold
32
$9.15 (40.04%)
29
1 months 26 days ago
5/6 (83.33%)
$0.98 (5.51%)
26
Which stock is Charles Duncan is most bullish on?
Which stock is Charles Duncan is most reserved on?
What Year was the first public recommendation made by Charles Duncan?
